Momentum in June

-----As we move through June, our focus remains clear—fighting for justice, driving meaningful change, and delivering results for our clients.

-----While some updates may not reflect major developments, rest assured that important work is always happening behind the scenes. Every motion filed, hearing attended, and negotiation held moves us closer to resolution.

-----Thank you for your continued trust. Together, we’re making progress—and making a difference.

-----Preparation continues for the first trials involving representative cases of kidney cancer, bladder cancer, NHL, leukemia, and Parkinson’s Disease. Depositions of experts for both sides have been taken, and the Court is actively involved in finalizing the issues for trial. Those issues will involve not only those five injuries, but also a detailed presentation of the history of water contamination over the approximately 35 years covered by the Camp Lejeune Justice Act. This is important since the government is contesting the argument that all chemicals were in the water from the beginning to the end of that time frame, and also that certain parts of the base were more affected than others. The work being done on this issue will affect future trials and the ultimate settlement of these cases as well.

-----While that is going on, settlement negotiations continue and are expected to pick up over the summer, with questionnaires to representative plaintiffs and formal mediation talks. With claims being filed for well over 100 different types of injuries, these negotiations are complicated. We will keep you updated as additional details are announced.

-----Finally, the Navy continues to make settlement offers under its Elective Option program. We will contact you directly with any such offer, so we can discuss the specifics and how they might affect you. 

Paraquat: Settlement Terms Still Being Finalized

-----The Court has acknowledged that a settlement is about to be announced and is allowing both sides to delay deadlines in preparing for the upcoming October trial. That trial is still set, however, and will move forward if the settlement isn’t finalized. It is understood that the terms of the settlement are close to being completed and should be announced shortly. We will immediately analyze that settlement and reach out directly to each of you with that additional information and how it would affect your case.

PFAS/AFFF: Preparations for Upcoming Trials Continue

-----The first trials remain set for this October, and work continues on both sides. The specific injuries for that first round are kidney and testicular cancer. During this same period, the Court is hearing arguments on liver and thyroid cancer and is expected to rule on whether to allow those to move forward by the end of the year. Finally, work also continues on the representative thyroid disease and ulcerative colitis cases set for early next year. Hopefully, this work will push all of these cases toward settlement so that some or all of these scheduled trials will not be necessary.

Hair Relaxer: Bellwether Case Selections

-----The parties and the court continue the process of selecting some sample cases, which will then be set for trial. These selections are known as Bellwether cases. Once these test cases go to trial, the jury outcomes will provide the parties with insight into possible outcomes, which can lead to a global settlement.

Asbestos: Mesothelioma, Lung Cancer, and Other Cancer Claims

-----OnderLaw’s Asbestos Team has the experience and resources to investigate and obtain compensation for you or your loved one.

-----Asbestos exposure has been known to cause (1) Mesothelioma, (2) Lung Cancer, (3) Throat Cancer, and (4) Colon Cancer.

-----Even if you are a smoker or past smoker, you are still eligible for compensation. In fact, smokers who were exposed to asbestos are more likely to develop cancer.

Because asbestos was commonly used before the 1980s, workers in many different fields were at risk for exposure:



• Military Veterans – Navy, Army, Air Force, Marines, National Guard
• Construction Workers, especially those who worked with or around drywall, joint compounds, ceiling tiles, floor tiles, roofing materials, plaster, insulation, and pipes.
• Insulators
• Plumbers / Pipefitters
• Electricians
• Boilermakers
• HVAC Technicians
• Auto Mechanics
• Shipyard Workers
• Power Plant Workers
• Chemical Plant Workers
• Firefighters
• Railroad Workers

-----Spouses and children have also been put at risk of developing these cancers from coming into contact with clothing worn by their spouse or parent at these workplaces.



-----If we have reached out to you to provide signatures or documentation, please return them promptly.

-----To contact our team about starting a case, please reach out to us at 314-227-7709.

Truvada/TDF: Litigation Updates

-----As the Truvada/TDF lawyers have been informing you for many months, this litigation remains on hold pending, first, the Court of Appeal's review of our trial court’s decision and now the California Supreme Court's review.

-----Based on the high Court’s summer schedule, we are unlikely to have a ruling until at least the fall. Please note that we are unable to force a ruling and are left to wait, which is difficult for us all. We acknowledge and agree that the long wait is frustrating. Until the ruling is issued, we cannot set trials or encourage defendants to settle or resolve your case.

-----We will, of course, advise you as soon as we receive any news relating to the Supreme Court’s ruling. In the interim, we appreciate your ongoing patience.

Sexual Abuse: Advocating for Survivors

-----OnderLaw is actively pursuing cases nationwide, advocating for survivors, and holding institutions accountable. At OnderLaw, we are dedicated to representing a wide range of sexual abuse survivors against Schools and Educational Institutions, Religious Organizations, Healthcare and Residential Facilities, Traumatic Brain Injury Rehabilitation Facilities, as well as Sports and Recreational Programs.

-----Our experienced team is working diligently to ensure that those responsible for enabling or failing to address abuse are held accountable. We understand that each case is unique, and our approach is tailored to meet each survivor's specific needs and circumstances.

-----If you or someone you know has experienced sexual abuse in an institutional setting, we encourage you to reach out to our Survivor Team in complete confidence. Our team is here to listen, offer support, answer questions, and provide confidential help.  

-----We are extremely close to finally reaching a settlement in the Roundup litigation.

-----As you are aware, we have been trying for a long time to reach a group settlement number. From there, a Settlement Special Master will divide the settlement money between the firm's clients, based upon the information provided on the claim form you filled out some time ago.

-----As previously indicated, Monsanto’s offer is significantly lower than we would like, but it reflects the risks of the current situation and Monsanto’s financial position. 

-----At present, the U.S. Supreme Court is considering whether to hear argument on the issue of whether Monsanto is immune from liability for failure to warn claims. Monsanto’s argument is that the EPA approved the Monsanto warning label, and refused to let Monsanto modify it, so it should be immune from liability for failure to warn, as it does not control the warning. There are contrary rulings from two separate circuits, which is typically when the Supreme Court addresses issue, i.e. in the event of a Circuit split. Given the Conservative nature of the current court, if the case is taken, all failure to warn claims could be dismissed and thrown out of Court. While other claims would be allowed to proceed, they are the much weaker claims, greatly decreasing value.

-----Monsanto has repeatedly indicated its intent to file bankruptcy, and we have reason to believe that such is its intention. The way it negotiated, the public statements that Roundup may be pulled from the market, the number of large verdicts against it, and the fact that Monsanto’s Roundup liability is but a fraction of its PCB liability, which lawsuits and verdicts are just beginning, all point to bankruptcy as the most effective way to cope with future liabilities.

-----In the event of bankruptcy, all lawsuits would stop, and immediate challenges would occur. Given the course of such bankruptcies, the attorney players involved, and other factors, we believe that it would most probably be at least another five years before anyone could hope to see a bankruptcy distribution.

-----Under the totality of the circumstances, we are negotiating what we believe to be in the best interests of our collective group of clients. From there, a Special Master will allocate the settlement money. If you have questions, or do not feel comfortable with the is approach, please let us know. We hope to be emailing, texting and writing to you soon with more detailed information. Thank you for your patience.  

Talcum Powder: Bankruptcy, Tort System, and Document Request

-----With Red River Talc’s bankruptcy dismissal, it is unlikely that J&J will file bankruptcy for a fourth time. J&J has made a public statement that it will not appeal the dismissal. Therefore, while we remain open to reasonable, good-faith negotiations with the defendants, Johnson & Johnson has not been interested in discussing a settlement; however, we are in regular communication with their counsel.  

-----As we will be returning to the tort system, we will communicate with those who still need to complete their Plaintiff Profile Forms. Please return the requested documents or signatures promptly. The timely receipt of the required information is extremely important.  

-----For the Talcum Powder Multi-District Litigation (MDL), Judge Shipp will hold a status conference on June 17, 2025. The conference will address motions that were pending when the Red River bankruptcy was filed, as well as the scheduling of bellwether trials, which were put on hold by the bankruptcy filing. We anticipate that a similar status conference will be scheduled in the New Jersey consolidated litigation in the coming weeks.

-----In the interim, the Philadelphia Consolidated Litigation judge has appointed a Mediator in an attempt to move the litigation toward settlement. We will be a part of any such discussion. 

-----Regardless of how it plays out, our goal is to hold J&J accountable for the harm it has caused to thousands of families and individuals.  

-----We continue to receive determination notices as files are reviewed and are sharing them as they are received. Our team is also busy reviewing the most serious injury claims for possible inclusion in the EIF program, which closes at the end of the month.

-----As you will recall, the federal judicial panel (JPML) ordered the federal coordinated proceeding (MDL) to be held in the Northern District of Florida before the Honorable M. Casey Rodgers. 

-----The judge has already issued numerous orders and selected five pilot cases to be worked up and briefed on important preliminary legal issues.

-----To date, we have filed several cases in the MDL. Once we have filed your lawsuit, we are ordered to comply with a court order to file proof of your use of Depo-Provera and meningioma injury. As such, our team may reach out to you in this regard. If you have new contact information, please update our office. We appreciate your prompt return of our phone calls and emails, especially when we have left you messages.

-----For all of our cases, we continue to order and collect your medical records to substantiate your claims. Our team may contact you from time to time for assistance with this process.

IVC Filter: Litigation Update

-----Cook IVC Filter Litigation: As you know, we complied with two Court Orders last summer, providing case categorization based on IVC filter injury and providing certification of the amount in controversy (a procedural hurdle). We greatly appreciated your assistance in meeting these Court Orders. Leadership in this litigation is meeting with Magistrate Judge Baker to discuss settlement. We will apprise you of the outcome of that meeting and the next steps in this litigation.

-----Cordis IVC Filter Litigation: As you know, this case reached a global settlement, and we are receiving and dispersing settlement funds in tranches of cases as settlement counsel processes them. To date, we have received and distributed two tranches of settlement funds for groups of cases included in those tranches. When we receive a list of cases with your matter included, we will contact you and make arrangements to send you a Distribution Statement for your review and signature. Once we receive your signed Distribution Statement, we will mail you your settlement check. Therefore, the team will reach out to you upon receipt of your settlement funds. Please update our office with any new contact information and promptly return our phone calls and emails when we have left you messages.

Zantac: Litigation Update

-----Delaware Litigation: As you are aware, we have reached a global settlement agreement with the GSK Defendants for eligible cases. We have been and will continue to contact all clients with cases eligible for the GSK settlement. If you have new contact information, please update our office. Additionally, please return our phone calls promptly, even if we have left you a message.

Additionally, as we have previously informed you, Defendants are appealing the Court’s Daubert rulings, which were favorable to Plaintiffs. The appeal is fully briefed, and the oral arguments were heard on April 16, 2025. We hope to have the Court’s decision sometime in the summer or fall. Nevertheless, the litigation is not stayed, and our discovery obligations remain in place. With your help, for nearly all our clients, we met the Court Order, submitting a Declaration (sworn statement) of Zantac use by October 31, 2024, and submitted medical records with proof of cancer diagnosis on January 31, 2025. For any case where we were unable to submit a Declaration for proof of use of Zantac and/or proof of cancer injury, we anticipate receipt of a motion to dismiss your lawsuit. As such, if our paralegals or attorneys are reaching out to you, please return their calls or texts. Considering the appeal, our Judge moved the May 2025 bellwether trial to September 15, 2025.

-----California Judicial Council Coordination Proceedings: As you are aware, we have also reached a global settlement agreement with the GSK Defendants for eligible cases filed in the California JCCP. We have been and will continue to contact all clients with cases eligible for the GSK settlement. If you have new contact information, please update us by getting in touch with our office. Additionally, please return our phone calls promptly if we have left you a message to contact us.

-----The Sanofi Defendants are also settling cases filed in the CA JCCP. Unfortunately, this settlement does not include the cases filed in Delaware. For the DE cases, we suspect the Defendants are waiting for the Daubert ruling before deciding on resolution.

-----For the Sanofi settlement, we have been in contact with you to assist you in completing and submitting your claim forms. This will help determine if you are eligible for the settlement and, if so, the allocation of settlement funds for your case. 

-----Our new Judge in the JCCP has set a trial for a group of 40 cases for September 2025. OnderLaw represents none of these cases.

-----MDL/Federal Proceedings: As we previously advised, Plaintiffs lost to Defendants’ Daubert challenges in the MDL. Plaintiffs' counsel submitted an appeal in an attempt to reserve this decision to the 11th Circuit, but we do not yet have an oral argument date. Therefore, the MDL is currently inactive until the 11th Circuit rules. We will have a better idea of the litigation timeline once we receive the hearing date, which we hope will be sometime in the fall of 2025.

Opioids: Bankruptcy Trust Active

-----While the Purdue bankruptcy is still proceeding through the stages necessary to get approval of the newest proposal, the trust created by that bankruptcy is finally working to be established so that there won’t be additional delays. We still expect several more months before even the bankruptcy court approves the new plan, and we will keep you posted. As for NAS deadlines, we are still awaiting word for the Endo Trust now that the deadline has passed for those who were eligible. The Mallinckrodt deadline is also approaching for those NAS cases that are eligible, and we expect payments to be announced after the June 15^th deadline. 

Tasigna: Settlement Agreement Reached

-----After years of effort, we have reached a settlement agreement with the defendant. You should have recently received an essential package from us with details about the settlement program. To participate in the settlement and receive your award, please sign the included forms immediately and return the entire package in the prepaid return envelope. Failure to return these materials will result in the forfeiture of your share of the settlement.

FAQs

Click on the question below to be directed to a blog that answers the question:

Questions?

Please Fill Out the Form Below:

Confidentiality Notice: The information contained in this communication is strictly limited to the recipient intended by the sender of this communication. This email, and any attachments, may contain confidential attorney-client privileged information and attorney work product. Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return email and destroy this communication and all copies thereof, including all attachments. ***DISCLAIMER*** Per Treasury Department Circular 230: Any U.S. federal tax advice contained in this communication (including any attachments) is not intended or written to be used, and cannot be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to another party any transaction or matter addressed herein. The information you obtain in this newsletter is not, nor is it intended to be, legal advice. It is confidential communication and should not be shared through mail, email, or on social media networks. Past litigation results afford no guarantee of future results. Every case is different, and must be judged based on its own merit. Consult an attorney for advice regarding your individual situation.

We invite you to contact us and welcome your calls and emails. If you are NOT a current OnderLaw client, contacting us does not create an attorney-client relationship. Please do not send any confidential information to us until such time as an attorney-client relationship has been established.